Filing Details
- Accession Number:
- 0001225208-22-003275
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-24 16:18:03
- Reporting Period:
- 2022-02-22
- Accepted Time:
- 2022-02-24 16:18:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595612 | J. Daniel Brennan | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-22 | 16,863 | $17.26 | 289,689 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-22 | 15,086 | $16.31 | 304,775 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-22 | 13,661 | $13.08 | 318,436 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-22 | 7,572 | $7.39 | 326,008 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-22 | 53,182 | $42.75 | 272,826 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Share Units | Acquisiton | 2022-02-22 | 23,979 | $0.00 | 23,979 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-22 | 16,863 | $0.00 | 16,863 | $17.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-22 | 15,086 | $0.00 | 15,086 | $16.31 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-22 | 13,661 | $0.00 | 13,661 | $13.08 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-22 | 7,572 | $0.00 | 7,572 | $7.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,979 | 2023-12-31 | 2023-12-31 | No | 4 | A | Direct |
| 50,591 | 2026-02-22 | No | 4 | M | Direct | |
| 45,259 | 2025-02-23 | No | 4 | M | Direct | |
| 27,323 | 2024-02-24 | No | 4 | M | Direct | |
| 7,572 | 2023-02-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $42.48 to $43.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
Billionaire Hedge Funds
